CRISPR Trial Provides Hope for Inherited Blindness - Neuroscience News - DRAFT Capital

A recent clinical trial, BRILLIANCE demonstrated the safety and efficacy of CRISPR gene editing in treating inherited blindness caused by mutations in the CEP290 gene.
— Read on neurosciencenews.com/crispr-genetics-vision-blindness-26038/

Posted in Investor and tagged blindness, CRISPR, eye sight, eyes, gene editing, restoration, vision

Leave a Comment Cancel Reply

You must be logged in to post a comment.